异常血红蛋白的诊断与筛查
本文综述了血红蛋白病(地中海贫血和结构血红蛋白变异体)在临床筛查与研究中的多种分析技术、研究方法和人工智能应用。近期阳离子交换高效液相色谱、毛细管区带电泳、等电聚焦、流式细胞术、质谱和聚合酶链反应等技术的进展,结合人工智能与便携式床旁检测,实现了对异常血红蛋白的明确检测。充分使用和改进现有诊断与筛查技术对血红蛋白病的控制和管理至关重要。
要点
- 阳离子交换HPLC、CZE、IEF、流式细胞术、质谱和PCR等技术进展支持异常血红蛋白的检测。
- 人工智能与便携式POCT整合智能手机显微分类、机器学习模型、CBC、影像方法等用于筛查。
- PCR、RT-PCR、DNA微阵列和测序等基因技术用于确认和验证未知及新型血红蛋白。
核心结论
- 充分使用和改进现有诊断与筛查技术对血红蛋白病的控制和管理具有重要意义。
研究设计与样本
- 综述总结了近期异常血红蛋白检测、研究方法和人工智能应用方面的进展与突破,以及当前限制和困难。
主要发现
- 阳离子交换HPLC、CZE、IEF、流式细胞术、质谱和PCR等进展允许通过先进AI和便携式POCT进行明确检测。
- 便携式POCT可整合智能手机显微分类、机器学习模型、全血细胞计数、影像方法、快速免疫分析和电化学、微流控及传感相关平台。
- PCR、RT-PCR、DNA微阵列、基因组DNA测序和RT-PCR扩增珠蛋白cDNA测序用于确认和验证未知及新型血红蛋白。
临床怎么用
- 临床筛查和研究血红蛋白病时可综合考虑HPLC、CZE、IEF、流式细胞术、质谱和PCR等技术。
- 可利用AI与便携式POCT整合机器学习模型、CBC和影像方法等辅助检测异常血红蛋白。
- 对未知或新型血红蛋白可使用基因测序技术进行确认和验证。
局限性
- 综述指出当前在血红蛋白病检测、研究方法和AI应用方面仍存在限制和困难。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hemoglobin (Hb) abnormalities, such as thalassemia and structural Hb variants, are among the most prevalent inherited diseases and are associated with significant mortality and morbidity worldwide. However, there were not comprehensive reviews focusing on different clinical analytical techniques, research methods and artificial intelligence (AI) used in clinical screening and research on hemoglobinopathies. Hence the review offers a comprehensive summary of recent advancements and breakthroughs in the detection of aberrant Hbs, research methods and AI uses as well as the present restrictions anddifficulties in hemoglobinopathies. Recent advances in cation exchange high performance liquid chromatography (HPLC), capillary zone electrophoresis (CZE), isoelectric focusing (IEF), flow cytometry, mass spectrometry (MS) and polymerase chain reaction (PCR) etc have allowed for the definitive detection by using advanced AIand portable point of care tests (POCT) integrating with smartphone microscopic classification, machine learning (ML) model, complete blood counts (CBC), imaging-based method, speedy immunoassay, and electrochemical-, microfluidic- and sensing-related platforms. In addition, to confirm and validate unidentified and novel Hbs, highly specialized genetic based techniques like PCR, reverse transcribed (RT)-PCR, DNA microarray, sequencing of genomic DNA, and sequencing of RT-PCR amplified globin cDNA of the gene of interest have been used. Hence, adequate utilization and improvement of available diagnostic and screening technologies are important for the control and management of hemoglobinopathies.
引用
- Sani A, Idrees Khan M, Shah S, et al. Diagnosis and screening of abnormal hemoglobins. Clin Chim Acta. 2023. PMID: 38030031. doi:10.1016/j.cca.2023.117685
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。